Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event
Lixte Biotechnology Holdings, Inc. to Present at August 20th Virtual Investor Summit Microcap Event
Take a deep dive with the best Investors in MicroCapNEW YORK, NY / ACCESSWIRE / August 14, 2024 / Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) is a clinical-stage pharmaceutical company focused on new targets for cancer drug development and developing and commercializing cancer therapies. The company will be available for 1-on-1 meetings throughout the day in addition to their presentation.
Lixte生物技術控股公司（納斯達克股票代碼：LIXT）是一家專注於癌症藥物開發的臨床階段藥品公司，致力於開發和商業化新的癌症治療方法。該公司除了進行演講外，還將在整個一天內提供1對1的會議。
Event: Q3 Investor Summit
Date: August 20th, 2024
Presentation Time: 2:00 pm ET
Location:
活動：Q3投資者峯會
日期：2024年8月20日
演講時間：東部時間下午2點
位置：
The theme is 50 micro-cap companies with a catalyst and/or strong performance in the current market.
Take a deep dive with the best Investors in MicroCap
Live Q & A
Complimentary to Qualified Investors. Please REGISTER HERE.
本次峯會主題是在當前市場上有催化劑和/或強勁表現的50個小市值公司。
與MicroCap最佳投資者深入探討。
實時問答。
僅供合格投資者免費註冊。請在此處註冊。
About the Investor Summit
The Investor Summit is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. Founded in 2015.
關於投資者峯會
投資者峯會是一家專注於連接小市值和微市值公司與合格投資者的獨立會議。創立於2015年。
Contact:
Fred Rockwell
fred@investorsummitgroup.com
Investor Summit Group
SOURCE: Lixte Biotechnology Holdings, Inc.
聯繫方式：
弗雷德·洛克威爾
fred@investorsummitgroup.com
投資者峯會集團
消息來源：Lixte生物技術控股公司。
